Table 4.
Patient# | Age at D/C (months) | FU time (months) | LVEF at 1 month (%) | LVEF at 3 months (%) | LVEF at 6 months (%) | LVEF at 12 months (%) | BD (days post-PAB) |
BW (kg, percentile) |
Medications | Ross class | Final outcome |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 9.9 | 55.7 | 25 | NA | NA | NA | NA | 8, 10th percentile |
Immunosuppressant | I | ECMO → HT∧ |
2* | 55 | 49.2 | 13 | NA | NA | NA | NA | 12, 3rd percentile |
Immunosuppressant | I | BH → HT° |
3 | 5.7 | 37.5 | 24 | 19 | 30 | 56 | 566 | 13, 50th percentile |
ASA, metoprolol, lisinopril | I | Recovery |
4 | 13.7 | 30.2 | 32 | 27 | 22 | 19 | 149 and 233 | 11, 3rd−10th percentile |
ASA lisinopril, bisoprolol, spironolactone, furosemide | I | Recovery |
5 | 8.8 | 25.4 | 13 | 31 | 38 | 55 | 327 | 11, 10th−25th percentile |
ASA, lisinopril, bisoprolol, spironolactone | I | Recovery |
ASA, acetylsalicylic acid; BD, balloon dilation; BH, Berlin Heart; BW, body weight; D/C, discharge; ECMO, extracorporeal membrane oxygenation; FU, follow-up; HT, heart transplant; LVEF, left ventricular ejection fraction; NA, not applicable; PAB, pulmonary artery banding; OHT, orthotopic heart transplant.
the patient experienced infectious pneumonia at home 2 months after PAB (another hospital), followed by cardiogenic shock; he was transferred to other hospital, where ECMO, and successful OHT were performed.
owing to hemodynamic instability, the patient required implantation of Berlin Heart 33 days after PAB and subsequent successful OHT 13 months after PAB. He was weaned off from mechanical ventilation for the first time 14 days after Berlin Heart implantation.